In the latest trading session,, 0.76 million OKYO Pharma Limited (NASDAQ:OKYO) shares changed hands as the company’s beta touched -0.25. With the company’s most recent per share price at $2.16 changing hands around $0.09 or 4.41% at last look, the market valuation stands at $73.25M. OKYO’s last price was a premium, traded about 1.39% off its 52-week high of $2.13. The share price had its 52-week low at $0.81, which suggests the last value was 62.5% up since then.

Analysts gave the OKYO Pharma Limited (OKYO) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.00. If we narrow down to specifics, the data shows that 0 out of 1 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended OKYO as a Hold, 1 felt it is a Buy and 0 rated the stock as Underweight. OKYO Pharma Limited’s EPS for the current quarter is expected to be 0.

OKYO Pharma Limited (NASDAQ:OKYO) trade information

Instantly OKYO is in green as seen in intraday trades today. With action 14.96%, the performance over the past five days has been green. The company’s shares are showing year-to-date upside of 87.96%, with the 5-day performance at 14.96% in the green. However, in the 30-day time frame, OKYO Pharma Limited (NASDAQ:OKYO) is 56.62% up.

The estimates for the next quarter sales put growth at 0.00%.

Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -126.59%. The 2025 estimates are for OKYO Pharma Limited earnings to increase by 57.50%.

OKYO Dividends

OKYO Pharma Limited is expected to release its next quarterly earnings report in July.

With 12.09 shares estimated at $26235.0 under it, the former controlled 0.04% of total outstanding shares.